Online citations, reference lists, and bibliographies.

Risk Of Vertebral Compression Fractures In Multiple Myeloma Patients

D. Anitha, Baum Thomas, K. S. Jan, K. Subburaj
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The purpose of this study was to develop and validate a finite element (FE) model to predict vertebral bone strength in vitro using multidetector computed tomography (MDCT) images in multiple myeloma (MM) patients, to serve as a complementing tool to assess fracture risk. In addition, it also aims to differentiate MM patients with and without vertebral compression fractures (VCFs) by performing FE analysis on vertebra segments (T1–L5) obtained from in vivo routine MDCT imaging scans. MDCT-based FE models were developed from the in vitro vertebrae samples and were then applied to the in vivo vertebrae segments of MM patients (n = 4) after validation. Predicted fracture load using FE models correlated significantly with experimentally measured failure load (r = 0.85, P < 0.001). Interestingly, an erratic behavior was observed in patients with fractures (n = 2) and a more gradual change in FE-predicted strength values in patients without fractures (n = 2). Severe geometric deformations were also observed in models that have already attained fractures. Since BMD is not a reliable parameter for fracture risk prediction in MM subjects, it is necessary to use advanced tools such as FE analysis to predict individual fracture risk. If peaks are observed between adjacent segments in an MM patient, it can be safe to conclude that the spine is experiencing regions of structural instability. Such an FE visualization may have therapeutic consequences to prevent MM associated vertebral fractures.
This paper references
10.1016/S0021-9290(99)00099-8
Femoral strength is better predicted by finite element models than QCT and DXA.
D. Cody (1999)
10.1111/j.1365-2141.1969.tb01363.x
British Committee for Standards in Haematology
Yen‐Lin Chee (1969)
10.1007/s00198-007-0525-7
Secondary contributors to bone loss in osteoporosis related hip fractures
B. Edwards (2007)
10.1155/2015/108451
Bone-Immune Cell Crosstalk: Bone Diseases
G. Mori (2015)
10.1007/s00270-011-0111-4
Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients
G. Anselmetti (2011)
10.1634/theoncologist.2009-0003
Myeloma bone disease: recent advances in biology, diagnosis, and treatment.
O. Sezer (2009)
Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma.
Gianfranco Pittari (2006)
10.1200/JCO.2014.55.1028
Multiple myeloma in the older adult: better prospects, more challenges.
T. Wildes (2014)
Proximal femur specimens : automated 3 D trabecular bone mineral density analysis at 8 ment
MB Huber (2008)
10.1016/J.CCR.2004.10.020
Focus on multiple myeloma.
C. Mitsiades (2004)
10.1359/jbmr.070728
Structural Determinants of Vertebral Fracture Risk
L. J. Melton (2007)
10.14336/AD.2014.0621
Analysis of vertebral bone strength, fracture pattern, and fracture location: a validation study using a computed tomography-based nonlinear finite element analysis.
K. Imai (2015)
Secondary osteoporosis : pathophysiology and management
F. Mirza (2015)
10.1530/EJE-15-0118
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
F. Mirza (2015)
10.1148/radiol.2472070982
Proximal femur specimens: automated 3D trabecular bone mineral density analysis at multidetector CT--correlation with biomechanical strength measurement.
M. Huber (2008)
10.1002/jbmr.2069
Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans
D. Kopperdahl (2014)
10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G
Skeletal complications of malignancy
R. Coleman (1997)
10.1186/1471-2407-13-31
A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors
L. Groeneveldt (2012)
10.1016/j.berh.2009.09.008
Quantifying the material and structural determinants of bone strength.
M. Bouxsein (2009)
Optimal management of cancer treatmentinduced bone loss: considerations for elderly patients
K Tipples (2011)
Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone 2003;33:744–50
RP Crawford (2003)
10.1002/jbmr.2443
Association of QCT Bone Mineral Density and Bone Structure With Vertebral Fractures in Patients With Multiple Myeloma
J. Borggrefe (2015)
National Cancer Institute, Bethesda, MD:2016; http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016
N Howlader (1975)
SEER Cancer Statistics Review, 1975-2003
L. Ries (2006)
10.2165/11595820-000000000-00000
Optimal Management of Cancer Treatment-Induced Bone Loss
K. Tipples (2011)
10.1155/2013/104546
Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement
P. Tosi (2013)
Guidelines on the diagnosis and management of multiple myeloma
M Mulligan (2010)
10.1016/S0140-6736(02)08761-5
Diagnosis of osteoporosis and assessment of fracture risk
J. Kanis (2002)
10.1115/1.1589772
Quantitative computed tomography-based finite element models of the human lumbar vertebral body: effect of element size on stiffness, damage, and fracture strength predictions.
R. Crawford (2003)
10.1182/blood-2008-12-195008
A monoclonal gammopathy precedes multiple myeloma in most patients.
B. Weiss (2009)
Proximal femur specimens: automated 3D trabecular bone mineral density analysis at 8 ment. Radiology 2008;247:472–81
MB Huber (2008)
10.1016/S8756-3282(02)00779-2
Correlation of bone mineral density with strength and microstructural parameters of cortical bone in vitro.
N. Wachter (2002)
Acute vertebral compression fractures in patients with multiple myeloma: evaluation of vertebral body edema patterns on MR imaging and the implications for vertebroplasty.
K. Layton (2006)
10.1007/s00198-008-0750-8
Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method
K. Imai (2008)
SEER data submission, posted to the SEER web site
10.3949/ccjm.77a.09091
New tools for detecting occult monoclonal gammopathy, a cause of secondary osteoporosis
B. Faiman (2010)
10.1007/s00198-006-0074-5
Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone
V. Bousson (2006)
November 2015 SEER data submission, posted to the SEER web site
N Howlader (2016)
10.1016/1350-4533(95)97314-F
Relations of mechanical properties to density and CT numbers in human bone.
J. Rho (1995)
10.1007/s00198-013-2424-4
Implications of local osteoporosis on the efficacy of anti-resorptive drug treatment: a 3-year follow-up finite element study in risedronate-treated women
D. Anitha (2013)
10.3109/07357907.2011.584589
Characterizing and Predicting Pathologic Spine Fractures in Myeloma Patients With FDG PET/CT and MR Imaging
M. Mulligan (2011)
10.1016/S1350-4533(01)00045-5
Improved prediction of proximal femoral fracture load using nonlinear finite element models.
J. Keyak (2001)
10.1371/journal.pone.0116907
In-Vivo Assessment of Femoral Bone Strength Using Finite Element Analysis (FEA) Based on Routine MDCT Imaging: A Preliminary Study on Patients with Vertebral Fractures
Hans Liebl (2015)
Medicine (MEDICINE)
(2017)
10.1359/jbmr.080805
Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans
T. M. Keaveny (2008)
Correlation of
NJ Wachter
Skeletal complications of malignancy. Skeletal Complications of Malignancy Symposium
R E Coleman (1997)
10.1159/000162282
Prevalence of Monoclonal Gammopathy of Undetermined Significance/Myeloma in Patients with Acute Osteoporotic Vertebral Fractures
T. Golombick (2008)
10.1016/S8756-3282(03)00210-2
Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography.
R. Crawford (2003)
10.1002/(SICI)1097-4636(199607)31:3<373::AID-JBM11>3.0.CO;2-K
Postfailure compressive behavior of tibial trabecular bone in three anatomic directions.
J. Keyak (1996)
10.1002/jbmr.150
Relation of Vertebral Deformities to Bone Density, Structure, and Strength
L. J. Melton (2010)
10.1073/pnas.1401337111
Engineered nanomedicine for myeloma and bone microenvironment targeting
Archana Swami (2014)
10.1097/MD.0000000000002305
Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
Pei Hsu (2015)
10.1002/JOR.1100160305
Computed tomography‐based finite element analysis predicts failure loads and fracture patterns for vertebral sections
M. Silva (1998)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar